18 January, 2022
Throughout the end of 2021, here at Fortress we have been finalising our move into our new headquarters. Based in Antrim Technology Park, our custom built 30,000 square-foot facility is now open and a secure base for all our staff.
With the initial project announced in 2019 by the Fortress Diagnostics Directors, it was exciting to see the final stages finally coming into place. With over £8m invested in the new headquarters, Fortress have only the best Research and Development equipment to ensure our high quality products are kept to this great standard.
Research and Development is at the heart of the new Fortress Diagnostics headquarters, with eight high tech laboratories to implement the creation, testing and production of over 1000 Fortress Diagnostics products shipped to all four corners of the world.
All the team at Fortress are thrilled to have a new home with modern office space, high tech laboratories, warehouses and cold rooms for our award winning products, a spacious canteen, meeting rooms and a state of the art board room. With this expansion of space, Fortress are also currently working on creating new jobs and doubling our headcount over the next two years.
We are excited to start inviting our long term customers to view our new home. COVID-19 restrictions will be in place when we welcome customers to the company. For more information regarding our new headquarters and coming to visit the site in 2022, please email marketing@fortressdiagnostics.com and we will inform you as to when we are opening our doors to our customers.
About Fortress Diagnostics
Fortress Diagnostics is a multi-award-winning global provider of in vitro diagnostics (IVDs). Fortress Diagnostics develops, manufactures and supports an extensive portfolio of clinical diagnostic tests from their ISO 13485:2016-accredited facility in the United Kingdom. Through their global distribution network they provide highly accurate medical testing solutions to immunology, haematology and serological laboratories in hospitals, medical centres, clinics, blood banks and research institutions in over 100 international markets.
